VAERS reports by lot

GSK Varicella/Shingles lot J9B25: VAERS reports

56 VAERS reports list lot J9B25 as a GSK Varicella/Shingles vaccine, received between 2022-08-11 and 2024-05-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
56
Reports
2%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1835%
Neurological713%
Musculoskeletal612%
Injection-site / Local reaction612%
Dermatological (non-injection-site)510%
Gastrointestinal48%
Cardiac / Cardiovascular36%
Respiratory36%

Where reports came from

U.S. state of the reporter, where given (top 12).

District of Columbia26
Pennsylvania4
New York4
Maryland4
Wisconsin2
Minnesota1
Missouri1
Virginia1
Illinois1
New Jersey1
Michigan1
Massachusetts1

Reports by month received

2022-084
2022-093
2022-107
2022-122
2023-011
2023-031
2023-101
2023-127
2024-016
2024-025
2024-033
2024-045
2024-0511

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.